EVALUATION, OPTION AND LICENSE AGREEMENTEvaluation, Option and License Agreement • February 12th, 2020 • Ayala Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 12th, 2020 Company Industry JurisdictionCertain information marked as [***] has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.